Cas 52-24-4 Thiotepa Thioplex Alkylating Agent For Treat Cancer

Thiotepa(Thioplex) is an alkylating agent used to treat cancer. It is an analogue of N,N’,N’’- triethylenephosphoramide (TEPA). This molecule features tetrahedral phosphorus and is structurally akin to phosphate. It is derived from aziridine and thiophosphoryl chloride. Thiotepa has been previously used in the palliation of a wide variety of neoplastic diseases. The more consistent results have been seen in: adenocarcinoma of the breast, adenocarcinoma of the ovary, superficial papillary carcinoma of the urinary bladder and for controlling intracavitary effusions secondary to diffuse or localized neoplastic diseases of various serosal cavities.

Related Products:

Pritelivir mesylate; Capecitabine; Lomustine; Nimustine hydrochloride; KU-55933; Ganetespib; Onalespib; INNO-206 HCl salt; Aldoxorubicin; Pritelivir

[1]. Hagen B, et al. Metabolism and alkylating activity of thio-TEPA in rat liver slice incubation. Cancer Chemother Pharmacol. 1991;28(6):441-7.

[2]. Down JD, et al. Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice. Bone Marrow Transplant. 1998 Feb;21(4):327-30.